Nucleotide analogs
AssigneesThe Regents of the University of California, The United States Government as represented by the Department of Veterans Affairs
InventorsKarl Y. Hostetler, James R. Beadle, Nadejda Valiaeva
Life of this patent
Estimating the term…
Abstract
Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.
Claims39
A method for the treatment of human papilloma virus in a subject in need thereof comprising administering to the subject an effective amount of a compound selected from:
- or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.
A method for the treatment of a disease caused by human papilloma virus comprising administering an effective amount of a compound selected from
- or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier, to a host in need thereof.
Dependencies are inferred from the claim text.